Abstract
It is widely recognized that calcium ions play a vital role in many cell processes and in a variety of muscle tissues (particularly in the function of cardiac tissue and vascular smooth muscle). Since Fleckenstein et al. (1) in 1969 reported the inhibition of myocardial contractility by calcium antagonists, extensive investigation of the pharmacologic properties and the therapeutic applications of these drugs have been carried out in the last decade (2–11). These drugs are also known as “calcium antagonists”, “slow- channel inhibitors”, “calcium channel blockers” or “calcium entry blockers”.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Fleckenstein A, Tritthart B, Fleckenstein B, Herbst A, Grun G: Selective inhibition of myocardial contractility by competitive calcium antagonists (iproveratril, D600, prenylamine). Naunyn-Schmiedeberg’s Arch. Pharmacol., (264): 22 7–228, 1969.
Fleckenstein A: Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. (17): 149–166, 1977.
Bailey JC, Elharrar V, Zipes, DP: Slow-channel depolarization: Mechanism and control of arrhythmias. Annu. Rev. Med. 29:417–426, 1978.
Luchi RJ, Chahine RA, Raizner AE Coronary artery spasm. Ann. Int. Med. (91): 5441–449, 1979.
Rahwan RG, Piascik MF, Witiak DT: The role of calcium antagonism in the therapeutic action of drugs. Can. J. Physiol. Pharmcol. (57): 443–460, 1979.
Henry PD: Calcium ion antagonists: Mechanisms of action and clinical applications. Pract. Cardiol. (5): 145–156, 1979.
Triggle DJ, Swamy VC: Pharmacology of agents that affect calcium. Chest (78): 174–1 79, 1980.
Seminar on Calcium Channel Blockers, Part 1. Am. J. Cardiol. 46: 1045–1067, 1980.
Seminar on Calcium Channel Blockers, Part 2. Am. J. Cardiol. 47: 15 7–184, 1981.
Nayler WG: Calcium antagonists. Eur. Heart J. (1): 225–237, 1980.
Church J, Zsoter TT: Calcium antgonistic drugs: Mechanism of action. Can. J. Physiol. Pharmacol. (58): 254–264, 1980.
Berne RM: Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am. J. Physiol. (204): 317–322, 1963.
Rubio R, Berne RM: Release of adenosine by the normal myocardium in dog and its relationship to the regulation of coronary resistance. Circ. Res. (25): 407–415, 1969.
Berne RM: The role of adenosine in the regulation of coronary blood flow. Clrc. Res. (47): 807–813, 1980.
Dutta P, Mustafa SJ: Binding of adenosine to the crude plasma membrane fraction isolated from dog coronary and carotid arteries. J. Pharmacol. Exp. Ther. (214): 496–502, 1980.
Mustafa SJ: Cellular and molecular mechanisms of coronary flow regulation by adenosine. Mol. Cell. Biochem. (31): 67–87, 1980.
Lenke D, Brock N, Zechel HJ: Zur pharmakologie von 1,4-Bis (3-(3,4,5- trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepin (Dilazep, INN), einer neuen koronaraktiven substanz. Arzneim.-Forsch. (22):639–651, 1972.
Hockerts T, Bogelmann G: Investigations of the cardiac and circulatory action of 2,6-Bis(diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine. Arzneim.-Forsch. (9): 47–49, 1959.
Schaper WKA, Xhonneux R, Jageneau AHM, Janssen PAJ: The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator. J. Pharmac. (152): 265–274, 1966.
Sano N, Katsuki S, Kawada M: Enhancement of coronary vasodilator action of adenosine by 1,4-Bis[3(3,4,5-trimenthoxybenzoyloxy)-propyl]- perhydro-1,4-diazepine (Dilazep, INN). Arzneim.-Forsch. 22:1655–1658, 1972.
Buyniski JP, Losada M, Bierwagen ME, Gardier RW: Cerebral and coronary vascular effects of a symmetrical N,N’-disubstituted hexahydrodiazepine. J. Pharmacol. Exp. Ther. (181): 522–528, 1972.
Katano Y, Takeda K, Otorii T, Horii D, Imai S: Effects of dilazep, dipyridamole and hexobenzine on the heart and coronary circulation. Folia Pharmacol. Jopon. 70:305–314, 1974 (Abs. in English).
Mustafa SJ: Effects of coronary vasodilator drugs on the uptake and release of adenosine in cardiac cells. Biochem. Pharmacol. 28: 2617–2624, 1979.
Turnheim K, Pittner H, Kolassa N, Kraupp O: Relaxation of coronary artery strips by adenosine and acidosis. Eur. J. Pharmac. (41):217–220, 1977.
Schrader J, Rubio R, Berne RM: Inhibition of slow action potentials of guinea pig atria muscle by adenosine: A possible effect on Ca2+ influx. J. Mol. Cell. Cardiol. (7): 427–433, 1975.
Fenton RA, Bruttig SP, Rubio R, Berne RM: Effect of adenosine on calcium uptake by intact and cultured vascular smooth muscle. Am. J. Phsyiol. (242):H797–H804, 1982.
Griffith SG, Meghji P, Moody CJ, Burnstock G: 8-phenyltheophylline; A potent P1-purinoceptor antagonist. Eur. J. Pharmacol. (75): 61–64, 1981.
Thyrum PT: Inotropic stimuli and systolic transmembrane calcium flow in depolarized guinea-pig atria. J. Pharmacol. Exp. Ther. 188: 166–179, 1974.
Hashimoto K, Takeda K, Katano Y, Nakagawa Y, Tsukada T, Hashimoto T, Schimamoto N, Sakai K, Otorii T, Imai S: Effects of niludipine (Bay a 7168) on the cardiovascular system; with a note on its calcium- antagonistic effects. Arzneim.-Forsch. 29: 1368–1373, 1979.
Gross GJ, Diemer MJ, Warltier DC, Hardman HF: Relaxation of potassium-depolarized canine, bovine and porcine large coronary arteries by nitroglycerin, chromonar and two dihydropyridine calcium antagonists. Gen. Pharmac. (12): 199–204, 1981.
Askar AO, Mustafa SJ: Effect of calcium antagonists on the adenosine induced relaxation of bovine coronary arteries. (Abstr.). Fed. Proc. 41 (3): 1529, 1982.
Nabata H: Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials. Japan. J. Pharmacol. (27): 239–249, 1977.
Herlihy JT, Bockman EL, Berne RM, Rubio R: Adenosine relaxation of isolated vascular smooth muscle. Am. J. Physiol. (230): 1239–1243, 1976.
Foley DH, Amsterdam EA, Mason DT: Interactions of vasoactive effects of adenosine and potassium ion on isolated feline coronary artery smooth muscle. Circ. Res. (44): 207–215, 1979.
Verhaeghe RH: Action of adenosine and adenine nucleotides on dog’s isolated veins. Am. J. Physiol. (233) H114–H121, 1977.
Dutta P, Mustafa SJ, Jones AW: Effect of adenosine on the uptake and efflux of calcium by coronary arteries (Abstr.) Fed. Proc. 39 (3): 530, 1980.
Askar AO, Mustafa SJ: Interaction between calcium entry blockers and adenosine (Abstr.) Pharmacologists 25 (3): 244, 1983.
Imai S, Takeda K: Effect of vasodilators upon the isolated taenia coli of the guinea pig. J. Pharmacol. Exp. Therap. (156): 557–564, 1967.
Evans DS, Sehenden JA: Adenosine receptors mediating cardiac depression. Life Sei. (31): 2425–2432, 1982.
Collis MG: Evidence for an A1-adenosine receptor in the guinea pig atrium. Br. J. Pharmac. (78): 207–212, 1983.
Kucukhuseyin C, Kayaalp SO: Enhancement of the muscle effects of adenosine by lidoflazine and dipyridamole in isolated atria. Arch. Int. Pharmacodyn. (208): 243–250, 1974.
Perez JE, Borda L, Schuchleib R, Henry PD: Inotropic and chronotropic effects of vasodilators. J. Pharmacol. Exp. Ther. (221): 609–613, 1982.
Camilion de Hurtado MC, Cingolani HE: Interaction between calcium and slow channel blocking drugs on atrial rate. Naunyn-Schmiedeberg’s Arch. Pharmacol. 322:65–71, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Nakagawa, Y., Gudenzi, M., Mustafa, S.J. (1984). Comparison of Calcium Blocking Activities of Adenosine Potentiating Compounds With Calcium Blocking Drugs in Isolated Smooth Muscle and Atria. In: Sperelakis, N., Caulfield, J.B. (eds) Calcium Antagonists. Developments in Cardiovascular Medicine, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3810-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3810-9_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3812-3
Online ISBN: 978-1-4613-3810-9
eBook Packages: Springer Book Archive